Le T - Search Results

1

Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials.

Rashdan S, Yang H, Le T, Selby C, Gerber DE, Alvarez CA. Rashdan S, et al. Among authors: le t. Clin Drug Investig. 2021 Feb;41(2):161-167. doi: 10.1007/s40261-020-00994-4. Epub 2021 Jan 8. Clin Drug Investig. 2021. PMID: 33417195

2

Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study.

Brown TJ, Keshvani N, Gupta A, Yang H, Agrawal D, Le TC, Gerber DE, Alvarez CA. Brown TJ, et al. Support Care Cancer. 2020 Nov;28(11):5315-5321. doi: 10.1007/s00520-020-05364-6. Epub 2020 Mar 2. Support Care Cancer. 2020. PMID: 32124025

3

QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.

Le T, Yang H, Rashdan S, Link MS, Zaha VG, Alvarez C, Gerber DE. Le T, et al. Clin Lung Cancer. 2020 Jan;21(1):21-27.e5. doi: 10.1016/j.cllc.2019.07.008. Epub 2019 Nov 25. Clin Lung Cancer. 2020. PMID: 31780402 Free PMC article.

4

Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era.

Gonugunta AS, Von Itzstein MS, Hsiehchen D, Le T, Rashdan S, Yang H, Selby C, Alvarez C, Gerber DE. Gonugunta AS, et al. Among authors: le t. Clin Lung Cancer. 2023 Jan;24(1):11-17. doi: 10.1016/j.cllc.2022.09.005. Epub 2022 Sep 24. Clin Lung Cancer. 2023. PMID: 36253271 Free article.

5

ALK alterations and inhibition in lung cancer.

Le T, Gerber DE. Le T, et al. Semin Cancer Biol. 2017 Feb;42:81-88. doi: 10.1016/j.semcancer.2016.08.007. Epub 2016 Sep 13. Semin Cancer Biol. 2017. PMID: 27637426 Free PMC article. Review.

6

Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?

Le T, Minna JD, Gerber DE. Le T, et al. J Thorac Oncol. 2019 Mar;14(3):332-335. doi: 10.1016/j.jtho.2018.12.017. J Thorac Oncol. 2019. PMID: 30782379 Free article. No abstract available.

7

Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?

Le T, Gerber DE. Le T, et al. Cancers (Basel). 2019 Mar 15;11(3):366. doi: 10.3390/cancers11030366. Cancers (Basel). 2019. PMID: 30875928 Free PMC article. Review.

8

Upper lip metastasis of sarcomatoid carcinoma of the lung - an unusual site of disease: a case report.

Le T, Mayer M, Sailors J, Gerber DE, Truelson JM. Le T, et al. J Med Case Rep. 2017 Jan 19;11(1):18. doi: 10.1186/s13256-016-1178-y. J Med Case Rep. 2017. PMID: 28100268 Free PMC article.

9

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition.

Le T, Sailors J, Oliver DH, Mayer M, Hoskin S, Gerber DE. Le T, et al. Lung Cancer. 2017 Mar;105:14-16. doi: 10.1016/j.lungcan.2017.01.005. Epub 2017 Jan 11. Lung Cancer. 2017. PMID: 28236979 Free PMC article.

10

Implementation and Uptake of Rural Lung Cancer Screening.

Le T, Miller S, Berry E, Zamarripa S, Rodriguez A, Barkley B, Kandathil A, Brewington C, Argenbright KE, Gerber DE. Le T, et al. J Am Coll Radiol. 2022 Mar;19(3):480-487. doi: 10.1016/j.jacr.2021.12.003. Epub 2022 Feb 7. J Am Coll Radiol. 2022. PMID: 35143786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,868 results

Search Page